Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Update on the medical treatment of stable angina.

Gayet JL, Paganelli F, Cohen-Solal A.

Arch Cardiovasc Dis. 2011 Oct;104(10):536-44. doi: 10.1016/j.acvd.2011.08.001. Epub 2011 Oct 12. Review.

2.

[Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)].

Danchin N, Chadarevian R, Gayet JL, Licour M, Valensi P.

Ann Cardiol Angeiol (Paris). 2007 Apr;56(2):82-7. French.

PMID:
17484092
3.

Incidence of early adverse events surrounding direct current cardioversion of persistent atrial fibrillation. A cohort study of practices.

Guédon-Moreau L, Gayet JL, Galinier M, Frances Y, Lardoux H, Libersa C; Group of Pharmacology and Therapeutics of French Society of Cardiology.

Therapie. 2007 Jan-Feb;62(1):45-8. Epub 2007 Mar 21.

PMID:
17374347
4.

[Treatment with statins in general medicine: dosage and effectiveness. Results of the observational study STATIMED].

Amouyel P, Lamarque H, Gayet JL.

Arch Mal Coeur Vaiss. 2005 Dec;98(12):1206-11. French.

PMID:
16435599
5.

Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting.

Ferrières J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A.

Int J Cardiol. 2006 Oct 10;112(3):302-7. Epub 2005 Dec 1.

PMID:
16325285
8.

[Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor].

Bousquet P, Gayet JL.

Therapie. 2003 Mar-Apr;58(2):113-21. Review. French.

PMID:
12942850
9.

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Gayet JL; SCOPE Study Group.

J Hypertens. 2003 Sep;21(9):1771; author reply 1771-2. No abstract available.

PMID:
12923411
10.

[The best of clinical pharmacology in 2002].

Andréjak M, Gayet JL, Ambrosi P.

Arch Mal Coeur Vaiss. 2003 Jan;96 Spec No 1:41-50. Review. French.

PMID:
12613362
11.

The OPTIMAAL trial: losartan or captopril after acute myocardial infarction.

Gayet JL; Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan.

Lancet. 2002 Dec 7;360(9348):1884-5; author reply 1885. No abstract available.

PMID:
12480392
12.

[The best of 2001. Clinical pharmacology].

Ambrosi P, Gayet JL, Andréjak M.

Arch Mal Coeur Vaiss. 2002 Jan;95 Spec No 1(5 Spec 1):33-8. Review. French.

PMID:
11901897
13.

[Recommendations of the French Society of Cardiology concerning the treatment of myocardial infarction after the acute phase. Epidemiology and Prevention Group].

Delahaye F, Bory M, Cohen A, Danchin N, de Gevigney G, Dellinger A, Fraboulet JY, Gayet JL, Guize L, Iung B, Mabo P, Monpère C, Steg PG, Thomas D; Groupe épidémiologie et prévention.

Arch Mal Coeur Vaiss. 2001 Jul;94(7):697-738. Review. French. No abstract available.

PMID:
11494631
14.

[The best in 2000 on clinical pharmacology].

Andréjak M, Gayet JL, Ambrosi P.

Arch Mal Coeur Vaiss. 2001 Jan;94 Spec No 1:47-55. Review. French.

PMID:
11260838
15.

[The best of coronary artery disease in 1999].

Gayet JL.

Arch Mal Coeur Vaiss. 2000 Jan;93(1 Spec No):51-9. Review. French.

PMID:
10721448
16.

[Electron microscopic comparison of the antithrombotic potential of 2 low osmolality iodine contrast media in percutaneous transluminal coronary angioplasty].

Lefèvre T, Bernard A, Bertrand M, Lablanche JM, Cequier A, Espuglas E, Gayet JL, Gosselin G, Bonan R.

Arch Mal Coeur Vaiss. 1994 Feb;87(2):225-33. French.

PMID:
7802530
17.

Acceptability and efficacy of two associations of paracetamol with a central analgesic (dextropropoxyphene or codeine): comparison in osteoarthritis.

Boissier C, Perpoint B, Laporte-Simitsidis S, Mismetti P, Hocquart J, Gayet JL, Rambaud C, Queneau P, Decousus H.

J Clin Pharmacol. 1992 Nov;32(11):990-5.

PMID:
1474172
18.

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.

Ollivier JP, Durier P, Bussiere JL, Gayet JL.

Eur J Clin Pharmacol. 1990;38 Suppl 2:S164-6.

PMID:
1974509
19.

Electrophysiological effects of intravenous nicaïnoprol, a new antiarrhythmic agent, in 11 patients.

Libersa CC, Caron JF, Kacet S, Dagano J, Vincent A, Dupuis B, Gayet JL, Lekieffre JP.

Eur Heart J. 1988 Mar;9(3):271-8.

PMID:
3383868
20.

[Neurinoma of the posterior cerebral fossa and mitral valve prolapse. Possible association and study of possible peri-operative consequences on rhythm].

Gayet JL, Fischer G, Silie M, Perinetti M, Allouach K, Marchand A, Delaye J.

Ann Cardiol Angeiol (Paris). 1985 Oct;34(8):531-4. French.

PMID:
4083767

Supplemental Content

Loading ...
Support Center